Efficacy and safety of ecabet sodium on functional dyspepsia: A prospective, double-blinded, randomized, multi-center controlled trial

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 17

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

327

HTML

2498

Figures (1-1)

189

Tables (1-7)

183

Sum=3197

May 7, 2006 (publication date) through Nov 23, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. May 7, 2006; 12(17): 2756-2761
Published online May 7, 2006. doi: 10.3748/wjg.v12.i17.2756

Table 3 Global assessment of symptomatic improvement after 4 wk of medication

Pearson's chi-square test: P = 0.71.

Citation: Lee JH, Kim JJ, Hahm KB, Lee DH, Kim N, Kim SK, Park JJ, Choi SR, Lee JH, Lee ST, Lee EH, Rhee JC. Efficacy and safety of ecabet sodium on functional dyspepsia: A prospective, double-blinded, randomized, multi-center controlled trial. World J Gastroenterol 2006; 12(17): 2756-2761
URL: https://www.wjgnet.com/1007-9327/full/v12/i17/2756.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i17.2756